Development and Understanding of Novel Compounds Designed as Potential MRI Contrast Agents

The two last decades have witnessed the appearance and the successful development of magnetic resonance imaging (MRI) contrast agents (CAs). Though MRI, which has become an essential medical diagnostic tool, can be performed without contrast agents, its rather low sensitivity implies long and tedious examination times. This time can be considerably reduced by the use of CAs. Paramagnetic ion complexes, and particularly gadolinium (III) complexes, can thus significantly accelerate the longitudinal relaxation rate 1/T1 of the water proton, one of the most common parameters measured in MRI experiments. The relaxivity, the property describing the paramagnetic relaxation enhancement, or PRE, is mainly affected by four parameters : the number of water molecules in the inner coordination sphere of the complex, the proton exchange rate in this inner sphere, the rotational correlation times, related to the size of the molecule, and the electron spin relaxation rates. This work deals with the development of four new types of compounds designed as potential MRI T1 contrast agents. The four compounds have different properties and were therefore developed to observe different effect on the relaxivity. High-field CAs, medium-field CA aggregates, linear polymeric and nanoparticular CAs, and targeted CAs are the four different specificities studied in this work. The first compound, presented in Chapter II, is the tricephalous complex {Mes[Gd(DO3A)(H2O)2]}. This mid-size molecule was designed as a potential high-field CA. The standard complexation method does not lead to the complete complexation, most probably due to an intramolecular folding of the compound. The complexation is therefore performed in two steps : a complete pre-complexation with magnesium (II) followed by a transmetallation to replace Mg2+ by Gd3+ in the three complexation sites. This newly developed complexation method can be really useful to achieve complete complexation of mid-size molecules, where complexation